EN DE
STOCK COMPARISON

Jubilant Ingrevia vs Linde plc Ordinary Shares: Fair Value & Quality

Both stocks run through our valuation models. Here is how Jubilant Ingrevia (JUBLINGREA) and Linde plc Ordinary Shares (LIN) compare, as of Aug 18, 2026.

As of Aug 18, 2026, Fair Value Calculator sees Jubilant Ingrevia as the less overvalued of the two: Jubilant Ingrevia trades at ₹733 versus a fair value of ₹384 (-48%), while Linde plc Ordinary Shares trades at $474 versus $222 (-53%).
Jubilant Ingrevia
JUBLINGREA.NSE · INR · Health Care
-48%
upside to fair value
overvalued
Price₹733
Fair Value₹384
Quality54/100
Linde plc Ordinary Shares
LIN · USD · Materials
-53%
upside to fair value
overvalued
Price$474
Fair Value$222
Quality70/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Jubilant IngreviaLinde plc Ordinary Shares
Valuation
41.9×P/E (TTM)31.9×
2.41×P/S (TTM)6.95×
3.38×P/B6.30×
18.9×EV/EBITDA18.9×
PEG2.18×
0.8%Dividend yield1.2%
₹5.00Dividend per share$6.10
Profitability
6%Net margin20%
10%Operating margin28%
9%Return on equity18%
5%Return on assets7%
Growth
12%Revenue growth (YoY)8%
-2.5%Avg. growth/yr (3Y)0.6%
45.2%Avg. growth/yr (5Y)4.5%
Balance & size
0.10×Debt / equity0.54×
$1BMarket cap$241B
healthyGrowth qualityhealthy

Linde plc Ordinary Shares leads: 5 to 8 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Jubilant Ingreviaof which business quality 53 · market factors 57 Linde plc Ordinary Sharesof which business quality 66 · market factors 55
ProfitabilityMargins and returns on capital today
42
51
Quality GrowthAre margins and returns improving?
35
51
CashflowEarnings quality: real cash, not paper profit
38
64
Fin. StrengthBalance sheet, leverage, solvency risk
67
69
InvestmentDisciplined investing over empire-building
67
70
Low VolatilityCalm price path (market factor)
77
87
MomentumPrice trend over the last 3–12 months (market factor)
48
41
52W MomentumDistance to the 52-week high (market factor)
51
44
Net IssuanceBuybacks instead of dilution
82
100

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Jubilant Ingrevia

DCF Models₹550
Earnings-Based₹458
Dividend Discount₹88.41
Multiples₹351
Asset-Based₹133
Growth DCF₹387
Economic Profit₹197
Growth Earnings₹593

25 of 26 models see the stock below the current price.

Linde plc Ordinary Shares

DCF Models$211
Earnings-Based$132
Dividend Discount$116
Multiples$239
Asset-Based$55.42
Growth DCF$155
Economic Profit$156
Growth Earnings$204

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Jubilant Ingrevia
Bear ₹213Fair Value ₹384Bull ₹485
₹733 = current price (white tick)
Linde plc Ordinary Shares
Bear $121Fair Value $222Bull $291
$474 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Jubilant Ingrevia · Health Care

Quality score54 · above median
Fair value upside-48% · below median

Linde plc Ordinary Shares · Materials

Quality score70 · Top 25%
Fair value upside-53% · below median

Bottom line

As of Aug 18, 2026, Fair Value Calculator sees Jubilant Ingrevia as the less overvalued of the two: Jubilant Ingrevia trades at ₹733 versus a fair value of ₹384 (-48%), while Linde plc Ordinary Shares trades at $474 versus $222 (-53%).

Linde plc Ordinary Shares has the higher quality score (70/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.